These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20196869)

  • 1. Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.
    Cook AD; De Nardo CM; Braine EL; Turner AL; Vlahos R; Way KJ; Beckman SK; Lenzo JC; Hamilton JA
    Arthritis Res Ther; 2010; 12(2):R37. PubMed ID: 20196869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
    De Nardo CM; Lenzo JC; Pobjoy J; Hamilton JA; Cook AD
    Arthritis Res Ther; 2010; 12(5):R199. PubMed ID: 20973954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.
    Cook AD; Braine EL; Campbell IK; Hamilton JA
    Am J Pathol; 2002 Mar; 160(3):917-26. PubMed ID: 11891190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice.
    Hua H; Zhang R; Yu S; Wang H; Zhao Y; Yu S; Li W
    Allergol Immunopathol (Madr); 2011; 39(4):206-11. PubMed ID: 21339035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-type plasminogen activator deficiency exacerbates arthritis.
    Yang YH; Carmeliet P; Hamilton JA
    J Immunol; 2001 Jul; 167(2):1047-52. PubMed ID: 11441114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritis.
    Blüml S; Sahin E; Saferding V; Goncalves-Alves E; Hainzl E; Niederreiter B; Hladik A; Lohmeyer T; Brunner JS; Bonelli M; Koenders MI; van den Berg WB; Superti-Furga G; Smolen JS; Schabbauer G; Redlich K
    Arthritis Res Ther; 2015 Aug; 17(1):230. PubMed ID: 26307404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
    Li J; Ny A; Leonardsson G; Nandakumar KS; Holmdahl R; Ny T
    Am J Pathol; 2005 Mar; 166(3):783-92. PubMed ID: 15743790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis.
    Odobasic D; Yang Y; Muljadi RC; O'Sullivan KM; Kao W; Smith M; Morand EF; Holdsworth SR
    Arthritis Rheumatol; 2014 Apr; 66(4):907-17. PubMed ID: 24757143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis.
    He X; Liu J; Liang C; Badshah SA; Zheng K; Dang L; Guo B; Li D; Lu C; Guo Q; Fan D; Bian Y; Feng H; Xiao L; Pan X; Xiao C; Zhang B; Zhang G; Lu A
    EBioMedicine; 2019 Mar; 41():538-555. PubMed ID: 30824383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
    Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
    Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody.
    Pisitkun P; Claudio E; Ren N; Wang H; Siebenlist U
    Arthritis Rheum; 2010 Nov; 62(11):3334-44. PubMed ID: 20662069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
    Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
    Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overproduced bone marrow neutrophils in collagen-induced arthritis are primed for NETosis: An ignored pathological cell involving inflammatory arthritis.
    Xu D; Lin Y; Shen J; Zhang J; Wang J; Zhang Y; Zhang H; Ning L; Liu P; Li S; Zeng H; Lin J; Yu C
    Cell Prolif; 2020 Jul; 53(7):e12824. PubMed ID: 32567730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models.
    Almholt K; Hebsgaard JB; Nansen A; Andersson C; Pass J; Rønø B; Thygesen P; Pelzer H; Loftager M; Lund IK; Høyer-Hansen G; Frisch T; Jensen CH; Otte KS; Søe NH; Bartels EM; Andersen M; Bliddal H; Usher PA
    J Immunol; 2018 Feb; 200(3):957-965. PubMed ID: 29282305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased collagen-induced arthritis severity and adaptive immunity in MKK-6-deficient mice.
    Hammaker D; Topolewski K; Edgar M; Yoshizawa T; Fukushima A; Boyle DL; Burak EC; Sah RL; Firestein GS
    Arthritis Rheum; 2012 Mar; 64(3):678-87. PubMed ID: 21953132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.
    Cook AD; Turner AL; Braine EL; Pobjoy J; Lenzo JC; Hamilton JA
    Arthritis Rheum; 2011 Aug; 63(8):2340-51. PubMed ID: 21809323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
    Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
    BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.